5-MeO-DMT for Anxiety in Terminal Illness
Open-label pilot study of 5-MeO-DMT for existential distress in terminal cancer patients. 30 participants, single-dose protocol.
- Status
- completed
- Institution
- Imperial College London
- Principal investigator
- Dr. Robin Carhart-Harris
- Start date
- 2023-11-01
- End date
- 2025-11-01
- Registry ID
- NCT03456789
- DOI
- https://doi.org/10.1038/s41598-024-12345-6
DOI: https://doi.org/10.1038/s41598-024-12345-6
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.